Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anavex Life Sciences Corp. (AVXL) vs Compugen Ltd. (CGEN)

Anavex Life Sciences Corp. and Compugen Ltd. are both Biotechnology companies. Anavex Life Sciences Corp. and Compugen Ltd. are of similar size ($224.5M and $216.9M). Anavex Life Sciences Corp. has negative trailing earnings, so its P/E is not meaningful; Compugen Ltd. trades at 6.3×. Compugen Ltd. has the higher net margin (47.6% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Compugen Ltd. leads on 9 and Anavex Life Sciences Corp. on 2.

Valuation

Metric AVXL CGEN Biotechnology median
P/E n/m 6.26 7.88
P/S n/m 3.04 11.47
P/B 1.96 2.54 2.52
Price to free cash flow n/m 5.63 21.16
EV/EBITDA n/m 3.30 0.74
EV/Sales n/m 1.35 10.73
Earnings yield (6.30%) 15.97% (28.84%)
Free cash flow yield (13.28%) 17.78% (23.03%)

Profitability

Metric AVXL CGEN Biotechnology median
Gross margin — 86.89% 65.16%
Operating margin 0.00% 40.94% 0.00%
Net margin 0.00% 47.55% 0.00%
Free cash flow margin 0.00% 54.10% 0.00%
Return on equity (12.80%) 47.85% (57.72%)
Return on assets (11.70%) 23.86% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL CGEN Biotechnology median
Revenue growth (TTM) — 234.18% 5.64%
EPS growth (last fiscal year) (3.85%) 337.50% —
Revenue growth, 5-year CAGR — 105.20% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL CGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 5.72 4.73
Net debt to EBITDA 2.00 (4.65) 0.96

Dividend

Metric AVXL CGEN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AVXL CGEN Biotechnology median
Market cap 216.91m 224.51m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack